These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 16854074

  • 1. Development of small-molecule cyclin D1-ablative agents.
    Huang JW, Shiau CW, Yang J, Wang DS, Chiu HC, Chen CY, Chen CS.
    J Med Chem; 2006 Jul 27; 49(15):4684-9. PubMed ID: 16854074
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS.
    Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431
    [Abstract] [Full Text] [Related]

  • 3. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines.
    Colin C, Salamone S, Grillier-Vuissoz I, Boisbrun M, Kuntz S, Lecomte J, Chapleur Y, Flament S.
    Breast Cancer Res Treat; 2010 Nov 01; 124(1):101-10. PubMed ID: 20054646
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y, Ito I, Wayama M, Fujimura A, Akaogi K, Machida H, Nakajima Y, Kuroda T, Ohmori K, Murayama A, Kimura K, Yanagisawa J.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):145-8. PubMed ID: 18355447
    [Abstract] [Full Text] [Related]

  • 12. Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome.
    Mrówka P, Głodkowska E, Młynarczuk-Biały I, Biały L, Kuckelkorn U, Nowis D, Makowski M, Legat M, Gołab J.
    Acta Biochim Pol; 2008 May 23; 55(1):75-84. PubMed ID: 18327303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.
    Altiok N, Mezzadra H, Patel P, Koyuturk M, Altiok S.
    Breast Cancer Res Treat; 2008 May 23; 109(2):315-23. PubMed ID: 17638069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
    Little PJ, Ballinger ML, Survase S, Osman N, Ogru E, Geytenbeek S, Bruemmer D, Nigro J.
    J Cardiovasc Pharmacol; 2008 Mar 23; 51(3):274-9. PubMed ID: 18356692
    [Abstract] [Full Text] [Related]

  • 18. 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
    Tsou HR, Otteng M, Tran T, Floyd MB, Reich M, Birnberg G, Kutterer K, Ayral-Kaloustian S, Ravi M, Nilakantan R, Grillo M, McGinnis JP, Rabindran SK.
    J Med Chem; 2008 Jun 26; 51(12):3507-25. PubMed ID: 18494457
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.
    Fan YH, Chen H, Natarajan A, Guo Y, Harbinski F, Iyasere J, Christ W, Aktas H, Halperin JA.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2547-50. PubMed ID: 15109648
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.
    Salamone S, Colin C, Grillier-Vuissoz I, Kuntz S, Mazerbourg S, Flament S, Martin H, Richert L, Chapleur Y, Boisbrun M.
    Eur J Med Chem; 2012 May 17; 51():206-15. PubMed ID: 22409968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.